An in-depth look at public drug program spending in 2015 using drug claims data from the 10 drug programs that submit to CIHI’s National Prescription Drug Utilization Information System (NPDUIS) Database.
This report examines pan-Canadian trends in hospitalizations due to opioid poisoning related to patient demographics, clinical characteristics and provincial/territorial rates.
Who is being hospitalized and why? How do rates differ across Canada for opioid poisoning? Get answers to these questions and more in this infographic from CIHI.
This study is the first to describe pan-Canadian trends in hospitalizations due to opioid poisoning, including an analysis of emergency department visits in two provinces.
Highlights of prescription drug data availability, recent analytic products and related reports.
A dictionary of available drug claim and coverage data, data elements and respective definitions.
Summary of public drug plan design and policy information for programs participating in the National Prescription Drug Utilization Information System.
Summary of policy and design changes to public drug plans participating in the National Prescription Drug Utilization Information System.
Methodology and glossary of the Patient Cost Estimator, updated for 2016.
A list of the revisions made to the MIS Standards, effective April 1, 2013.
An overview of information on prescription drug abuse available through CIHI's data holdings.
A guide to prescription drug claims data related to prescription drug abuse.
A guide to hospital and emergency department data related to prescription drug abuse.
You must log in to access this file.
Aggregated prescription drug data for mental disorders in adolescents, showing prevalence by province, class, drug, region and demographic information.
Information on the changes in reporting for respiratory services for the MIS Standards 2016.
Study on the use of antipsychotics among seniors living in long-term care facilities, and on concurrent use with other psychotropic drugs.
Information on the use of antipsychotics among seniors living in long-term care facilities, and on concurrent use with other psychotropic drugs.